Login     Register  
    Home  |   Your Profile  |   Search  |   About Us  |   Contact Us  |   Disclaimer
BioOntario - Ag Biotech,  Biotechnology and Pharmaceutical Portal for Ontario Canada eyeforpharma
Site Search:
    Home Innovation Community Engaged Thinking News Directory Events
 Patient Engagement   Show all: Patient Engagement

Capturing the Value of Patient Engagement: Summary of Results of the Study of Patient-Centric Initiatives in Drug Development
Read this executive summary and detailed study results that include key insights in the following areas: adoption of patient-centric initiatives by pharmaceutical and biotech companies, barriers to adoption of patient-centric initiatives, comparative analytics and results of patient-centric initiatives.
Read More...

The Evolution of Patient Engagement at FDA
Although advancements in incorporating the patient voice have been made over the past few decades, there are still patients who feel frustrated with the rate of progress.
Read More...

Will GSK’s new ‘ethical’ approach to its customers deliver commercial success?
This is the question eyeforpharma answers in its latest whitepaper on GSK's radical new customer engagement model. Read the full paper here
https://goo.gl/w0H9k7

Lessons for Patient Driven Innovation: Rebuild Personas According to Your Next Product Innovation
By exclusively focusing on your persona’s one main need and trying hard to fulfill that need with your product, you can build the next feature with a more focused vision.
Read More...

Culture and Process Change for Patient Engagement
Patient Focused Medicines Development (PFMD) is a not-for-profit independent multinational coalition of patients, patient stakeholders, and the pharmaceutical industry with interests across diverse disease areas and conditions.
Read More...

Lessons on Design Thinking from P&G and Pfizer
Learn more on the how, and why, both P&G and Pfizer view design thinking as a tool set that helps individuals and companies problem-solve.
Read More...

Opening the Door to Patients
The Open House concept was born towards the end of 2014 when Janssen was approached by a large patient group in the oncology space. The group asked if the company would be interested in supporting them in work that they felt would contribute towards improving patient outcomes. As discussions progressed, it became clear that a new model of interaction might be appropriate.
Read More...

It takes two to tango: how shared decision making can help patients and providers make better decisions together
Shared Decision Making
Thursday, September 15, 2016 at 1 PM in Paul Brest Hall, Stanford University.
You make decisions every day. Some are good; some are not as good. Did you know there is a science to decision making that can help people make better decisions more often? In collaboration with Eli Lilly, Medicine X will facilitate a half-day design workshop about improving decision making for patients and providers.
Read More...

Do Patents Promote or Hinder Innovation
A petition recently filed with the Supreme Court triggers renewed debate about the role of patents in the diagnostics sector.
Read More...

Innovation Communities
The Communities of Practice concept is a key lever for innovation, but often overlooked. The best innovation programs leverage CoPs to support continuous innovation across an organization.
Read More...

WEBINAR: How Pfizer Built a Global Innovator Network
Pfizer's Daniel Seewald explores the keys to success in creating a global network of innovation “champions” over scarcely more than two years.
Read More...

Using the Internet to Raise Disease Awareness
The continued rise of social media and the various fundraiser pages can be great for any disease awareness campaign. Patients who have the diseases that are being campaigned for are more likely to engage via social media than the other campaign methods.
Read More...

Strategies for Patient Engagement
Positive and credible engagement of patients is critical for completion of clinical trials and to achieve business results. The CLEAR method leverages: credibility, literacy, expectation management, accessibility and that relates to patients.
Read More...
 
Precision Medicine Intiative
Precision Medicine is an innovative approach that takes into account individual differences in people’s genes, environments, and lifestyles.
Read More...

Patient Engagement Practices in Clinical Research among Patient Groups, Industry, and Academia in the United States: A Survey
This study aims to gain a better understanding of attitudes and practices for engaging patient groups.
 
Partnership between Pharma and Patients
Jane Griffiths, Company Group Chairman, Janssen EMEA discusses the relationship between industry and patients.
Read More...
 
Learning more from Patients Regarding Engagement
What can learn pharma from patients regarding engagement expectations including data collection, communication and the usage of technology.
Read More...

A Focus on People, Ideas and Culture: Bayers Model of Innovation
Bayer's model of innovation is a holistic model for people and their ideas. The model assists with the creation, nurturing, and enhancing of people and ideas.

Engaging patients for drug repurposing: Mapping the patient engagement continuum
November 2015

The chance exists to engage patients directly through crowd research and patient journey mapping as well as indirectly through patient health information to seek new opportunities for drug repurposing. Case examples are used in this article to shed light on programs that have been initiated by a variety of stakeholders including patients themselves to elucidate drugs that potentially are candidates for drug repurposing.
 
Patient Research Priorities
October 2015
Is there a disparity between what patients think are research priorities and the focus of academic/industry studies? Patients become experts in regard to disease and health management; their research priorities can often differ from those of academic/industry based researchers. 
Read More...

P
atient Engagment/Engaged Thinking Social Community Launched
September 18 2015
Visit CanBiotech's new patient engagement and engaged thinking community. Participate in the development of the concept of engaged thinking in health innovation and the identification of "lead patients".
Read More...

 
Listening to Patients
September 2015

In its own move to patient centricity, Sanofi seeks to use practical cases internally to illustrate to staff how things can change toward patient centricity.
Read More...

Fostering Behavior Change for Better Health

Using design thinking, researchers developed five distinct patient segments and created journey maps to chart the experiences of patients from each of these segments from diagnosis to long-term treatment adherence in the context of HIV management.
Read More...

Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes
September 2015

The collaboration will pair Sanofi’s leadership in diabetes treatments and devices with Google’s expertise in analytics, miniaturized electronics and low power chip design. The companies will explore how to improve diabetes care by developing new tools that bring together many of the previously siloed pieces of diabetes management and enable new kinds of interventions. This includes health indicators such as blood glucose and hemoglobin A1c levels, patient-reported information, medication regimens and sensor devices.

Read More...

The Lilly COI API and TrialReach: A Story of Innovation
August 2015

A vision for inclusive and participatory clinical knowledge generation, with particpation by all including patients in the clinical research ecosystem. Participatory is at the core of open innovation at Lilly.
Read More...

Patient Engagement and Cultural Competence
July 2015

Should the pharmaceutical industry consider cultural competence a driver for more holistic patient engagement? Care providers and health care organizations are seeking to align patient engagement and cultural competency to better understand disease management and compliance issues.
Read More...

Pfizer's Global Innovation Network
June 2015

In this webinar, Pfizer's Daniel Seewald explores the keys to success in creating a global network of innovation “champions”.
Read More...

An Interview with Novartis
June 2015

In this interview, the CEO of Swiss pharmaceutical company Novartis, Joseph Jimenez, discusseshow digitization is driving innovation, and why Novartis is shifting to an outcomes-based approach for patient treatments.
Read More...


Pharma Behind Other Industries in Customer Engagement

Expanded Patient Role
June 2015

Patient engagement can be traced across the drug-development pipeline including the impact of recent policy initiatives, and prospects moving forward.
Read More...

Exploring open innovation with a patient focus in drug discovery: an evolving paradigm of patient engagement
It is suggested in this article that patient engagement should occur further upstream during the drug discovery stage. ‘Lead patients’, namely those patients who are proactive with respect to their health, possess knowledge of their disease and resulting symptoms. They are also well informed about the conventional as well as non-conventional treatments for disease management; and so can provide a nuanced perspective to drug design.
Read More:
http://informahealthcare.com/doi/abs/10.1517/17460441.2015.1037271


Using the Site Privacy & Security Statement Advertise with us Directory Guide & Access Policy Event Postings CanBiotech Newsletters

© 2000-2017 CanBiotech™ Inc.